home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Preparing for Pre-approval Inspections - Webinar By GlobalCompliancePanel

 
  February 02, 2011  
     
 


GlobalCompliancePanel, Online Training Webinar
2011-04-19


Overview: This interactive webinar begins with an overview of the FDA Inspection process.

Preparation for the inspection in the months before, the immediate weeks before and on the day of the inspection will be discussed. The Inspection process will be reviewed followed by a detailed look at common focus area areas of Inspectors. Procedures to be followed after the inspection such as preparation of the response to 483s will be discussed. Ample discussion time will be available at the halfway point in the webinar and again at the end of the webinar.

Why you should attend: Pre-approval inspections provides a relatively narrow window of time during which the NDA/BLA/ANDA holder can demonstrate to the FDA that the quality systems at the site are in compliance with the GMPs and that appropriate facilities are available to support manufacture of the product. It is therefore important to present the organization in the best light possible.

Areas Covered In the Seminar:
  • Pre-Approval Inspections
  • Overview of the pre-approval inspection process
  • Preparation in the months preceding the inspection
  • Preparation on the day of the inspection
  • What to expect on inspection day
  • Responding to 483
Who will benefit: This course is intended to provide training how to prepare for FDA Pre-approval inspections.
  • QC Supervisors and Management
  • QA personnel
  • QA Management
  • Documentation management specialists
  • Regulatory affairs personnel
 
 
Organized by: GlobalCompliancePanel
Invited Speakers:
Dr. Subbarao received her Ph.D. in Bio-organic Chemistry from the Indian Institute of Technology, Bombay, India. Her hands-on industrial experience covers stability and laboratory cGMP systems for both biologics and conventional drugs. She has extensive experience in evaluation of analytical methods and method validation for products ranging from conventional drugs, well characterized proteins, vaccines, cell therapy and gene therapy products, ranging from pre-clinical phase to commercial phases. She is an ASQ Certified Quality Auditor with expertise in setup of cGMP/GLP complaint Quality Systems for laboratory and stability programs as well as upgrade of existing Quality Systems for products during development and in commercial phase. She is currently a Senior Consultant with the Biologics Consulting Group specializing in Analytical, Stability, CMC and GLP/GMP Quality Systems. She serves on the AAPS Stability Focus Group Steering Committee. She also serves on the AAPS National Biotechnology Conference Programming Committee for 2009 to 2011 as the Regulatory Sciences lead.
 
Deadline for Abstracts: 2011-04-19
 
Registration: Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00
E-mail: webinars@GlobalCompliancePanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.